Stockscreener 앱 받기
1.82
2.15%
-0.04
시간 외 거래:
1.82
전일 마감가:
$1.86
열려 있는:
$1.88
하루 거래량:
802.83K
Relative Volume:
0.71
시가총액:
$233.43M
수익:
$272.07M
순이익/손실:
$-248.06M
주가수익비율:
-0.9025
EPS:
-2.0167
순현금흐름:
$-16.48M
1주 성능:
+10.98%
1개월 성능:
+23.81%
6개월 성능:
-4.21%
1년 성능:
-17.27%
1일 변동 폭
$1.665
$1.90
1주일 범위
$1.63
$1.925
52주 변동 폭
$0.72
$3.22
Waldencast Plc Stock (WALD) Company Profile
명칭
Waldencast Plc
전화
(917) 546-6828
주소
10 BANK STREET, SUITE 560, WHITE PLAINS
Compare WALD vs PG, UL, CL, KVUE, KMB
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WALD
Waldencast Plc
|
1.82 | 238.56M | 272.07M | -248.06M | -16.48M | -2.0167 |
PG
Procter Gamble Co
|
150.46 | 348.38B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
58.69 | 127.59B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
90.58 | 71.58B | 20.80B | 2.22B | 3.77B | 2.5772 |
KVUE
Kenvue Inc
|
18.25 | 34.83B | 15.29B | 1.62B | 1.82B | 0.8433 |
KMB
Kimberly Clark Corp
|
103.14 | 33.95B | 16.56B | 1.75B | 1.84B | 6.36 |
Waldencast Plc Stock (WALD) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-14 | 재개 | Jefferies | Buy |
| 2025-11-25 | 다운그레이드 | Telsey Advisory Group | Outperform → Market Perform |
| 2025-04-22 | 개시 | Alliance Global Partners | Buy |
| 2024-12-16 | 개시 | TD Cowen | Hold |
| 2024-10-25 | 개시 | Canaccord Genuity | Buy |
| 2024-05-01 | 재확인 | Telsey Advisory Group | Outperform |
| 2023-07-24 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Waldencast Plc 주식(WALD)의 최신 뉴스
FDA approves Obagi saypha ChIQ filler from Waldencast (NASDAQ: WALD) - Stock Titan
Waldencast receives FDA approval for Obagi saypha ChIQ filler By Investing.com - Investing.com India
Waldencast receives FDA approval for Obagi saypha ChIQ filler - Investing.com
FDA approves Obagi cheek-augmentation filler for midface contour issues - Stock Titan
Waldencast Q4 2024 Earnings: EPS Misses Estimates Amidst Challenging QuarterPost-Earnings Drift - newsline.com
WALD Q4 2024 Earnings: Significant EPS Miss Raises Concerns Amidst Growth StrategyDividend Growth Analysis - newsline.com
Waldencast plc (WALD) Q4 2024 Earnings: Significant EPS Miss Highlights Profitability PressuresShare Dilution Risk - newsline.com
Watkins Advises Bridgepoint in Acquisition of Obagi Medical From Waldencast - Latham & Watkins LLP
Canaccord raises Waldencast stock price target on Obagi sale By Investing.com - Investing.com Australia
Canaccord raises Waldencast stock price target on Obagi sale - Investing.com
WALD ALERT: Hagens Berman, National Trial Attorneys, Encourages Waldencast plc (WALD) Investors with Substantial Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations - TMX Newsfile
Waldencast (WALD) Gains 3.28%: Testing Key Resistance Levels After Recent VolatilitySentiment Shift - newsline.com
Obagi Medical sold to Bridgepoint as Waldencast focuses on Milk Makeup brand - FashionNetwork USA
Waldencast Announces Sale of Obagi Medical To Bridgepoint - Happi | Household And Personal Products Industry
Waldencast agrees to sell Obagi Medical for up to $460 million By Investing.com - Investing.com India
Waldencast to Sell Obagi Medical to Bridgepoint for Up to $460 Million and Refocus on Milk Makeup - TipRanks
Waldencast plc Announces CEO Changes - marketscreener.com
Obagi sale lets Waldencast (NASDAQ: WALD) cut debt and focus Milk - Stock Titan
Waldencast Announces Sale of Obagi Medical to Bridgepoint - The Manila Times
Waldencast agrees to sell Obagi Medical for up to $460 million - Investing.com
Sale of Obagi for up to $460M lets Waldencast refocus on Milk Makeup - Stock Titan
Waldencast plc Warrant (WALDW) Surges 21.7%: Micro-Cap Warrant Sees Renewed InterestBear Pennant - newsline.com
WALD Q4 2024 Earnings: EPS Misses Estimates as Losses WidenRevenue Warning Signal - newsline.com
Waldencast's (WALD) CFO/COO Gautier Abruptly Exits Amid SEC's Investigation into Company's Improper AccountingHagens Berman - TMX Newsfile
Waldencast Warrants (WALDW) Edge Higher at $0.04 Amid Tight Trading RangeBullish Percent Index - The Legal Advocate
Waldencast (WALD) Q4 2024 Earnings: Significant EPS Miss Reflects Persistent Operational ChallengesRevenue Surprise History - Newser
Why Waldencast (WALDW) Just Dropped -14.89% — What to Watch 2026-05-20TRIN Signal - newsline.com
Waldencast plcClass A Ordinary Share (NQ: WALD - The Chronicle-Journal
Obagi Medical Shares New Data on Recent Innovations at - GlobeNewswire
Obagi study: 94% of injectors back new filler, serum tied to younger skin - Stock Titan
Obagi and Next Health Partner to Launch “The Skin Recharge Station” Pop-Up Experience - GlobeNewswire
TradingKey - TradingKey
How Waldencast (WALD) Story Is Shifting As Targets Fall And Brand Hopes Persist - Yahoo Finance
Waldencast PLC (NASDAQ:WALD) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Obagi Medical Unveils New Mineral Sunscreen Designed to Protect Sensitive and Post-Procedure Skin* - GlobeNewswire
Waldencast Stock Steadies As SEC Closes Probe On Obagi Accounting - timothysykes.com
Waldencast announces conclusion of SEC investigation - The Manila Times
Waldencast Clears SEC Probe Over Obagi-Related Accounting Issues - TipRanks
SEC closes Waldencast accounting probe, no enforcement planned - Stock Titan
Waldencast plc Exonerated by SEC Following Investigation into Financial Reporting Practices - Quiver Quantitative
SEC ends Waldencast (NASDAQ: WALD) investigation with no enforcement action - Stock Titan
SEC Drops Investigation Into Waldencast - marketscreener.com
WALD - Finviz
WALD Should I Buy - Intellectia AI
Waldencast (WALDW) Stock: Market Catalysts Overview (Smart Money Exits) 2026-04-22Shared Buy Zones - Xã Thanh Hà
Kelly Brookie Net Worth (2026) - GuruFocus
Waldencast (WALD) Stock Trending Today (Trend Weakens) 2026-04-18Verified Stock Signals - Cổng thông tin điện tử tỉnh Lào Cai
Manuel Manfredi Net Worth (2026) - GuruFocus
Waldencast Acquisition Corp (WALDW) - Minichart
Waldencast PLC (NASDAQ:WALD) Short Interest Down 19.3% in March - MarketBeat
Form 6-KReport of foreign issuer [Rules 13a-16 and 15d-16] - ADVFN
Waldencast Plc (WALD) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.32%
4.64%
자본화:
|
볼륨(24시간):